Intuitive Surgical, Inc. $ISRG Shares Purchased by CHICAGO TRUST Co NA

CHICAGO TRUST Co NA increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 2,009 shares of the medical equipment provider’s stock after acquiring an additional 665 shares during the quarter. CHICAGO TRUST Co NA’s holdings in Intuitive Surgical were worth $1,092,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Chilton Capital Management LLC boosted its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 43 shares during the period. Global Financial Private Client LLC boosted its stake in Intuitive Surgical by 253.3% during the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the period. Elite Financial Inc. purchased a new position in Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter worth about $30,000. Finally, TD Capital Management LLC boosted its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director directly owned 1,074 shares in the company, valued at approximately $504,898.14. This represents a 23.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $444.55 on Tuesday. The firm’s fifty day moving average price is $475.20 and its 200 day moving average price is $502.92. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The firm has a market cap of $159.36 billion, a price-to-earnings ratio of 62.00, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the firm posted $1.78 EPS. Intuitive Surgical’s quarterly revenue was up 21.4% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ISRG shares. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Evercore ISI raised their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. UBS Group raised their price objective on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.